Cargando…

Acylcarnitines: Reflecting or Inflicting Insulin Resistance?

Detalles Bibliográficos
Autores principales:	Schooneman, Marieke G., Vaz, Frédéric M., Houten, Sander M., Soeters, Maarten R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526046/ https://www.ncbi.nlm.nih.gov/pubmed/23258903 http://dx.doi.org/10.2337/db12-0466

Ejemplares similares

Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
por: Karpe, Fredrik, et al.
Publicado: (2011)

Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues
por: Makrecka-Kuka, Marina, et al.
Publicado: (2017)

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018)

Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
por: Bender, Shawn B., et al.
Publicado: (2013)

MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
por: Fernandez-Valverde, Selene L., et al.
Publicado: (2011)

CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction
por: Li, Tingting, et al.
Publicado: (2022)

Insulin Regulates Brain Function, but How Does It Get There?
por: Gray, Sarah M., et al.
Publicado: (2014)

Closing in on the Mechanisms of Pulsatile Insulin Secretion
por: Bertram, Richard, et al.
Publicado: (2018)

The Complex Mechanism of Glutamate Dehydrogenase in Insulin Secretion
por: Fahien, Leonard A., et al.
Publicado: (2011)

Learning From Past Failures of Oral Insulin Trials
por: Michels, Aaron W., et al.
Publicado: (2018)

Direct Autocrine Action of Insulin on β-Cells: Does It Make Physiological Sense?
por: Rhodes, Christopher J., et al.
Publicado: (2013)

β-Cell–Specific Gene Repression: A Mechanism to Protect Against Inappropriate or Maladjusted Insulin Secretion?
por: Schuit, Frans, et al.
Publicado: (2012)

Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
por: Nowak, Christoph, et al.
Publicado: (2018)

Historical Perspective: Beginnings of the β-Cell: Current Perspectives in β-Cell Development
por: Seymour, Philip A., et al.
Publicado: (2011)

Insulin resistance in the liver: Deficiency or excess of insulin?
por: Bazotte, Roberto B, et al.
Publicado: (2014)

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?
por: Wong, Eva Y., et al.
Publicado: (2021)

Self-Inflicted
Publicado: (1875)

Prolonged remission in latent autoimmune diabetes of adults (LADA): Is insulin resistance a major influence?
por: Rocha, José Vicente, et al.
Publicado: (2023)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

HDL as a Biomarker, Potential Therapeutic Target, and Therapy
por: Navab, Mohamad, et al.
Publicado: (2009)

Diabetes: Concepts of β-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention
por: Charles, M. Arthur, et al.
Publicado: (2021)

The significance of acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency
por: Shi, Congcong, et al.
Publicado: (2023)

Acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency in newborns
por: Tan, Yifei, et al.
Publicado: (2023)

Economic aspects in the management of diabetes in Italy
por: Marcellusi, A, et al.
Publicado: (2016)

Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge
por: Bain, James R., et al.
Publicado: (2009)

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
por: Naegeli, A N, et al.
Publicado: (2010)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
por: Moon, Hyun-Seuk, et al.
Publicado: (2011)

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer
por: Andersen, Dana K., et al.
Publicado: (2017)

Toward Engineering a Novel Transplantation Site for Human Pancreatic Islets
por: Smink, Alexandra M., et al.
Publicado: (2013)

SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
por: Obukhov, Alexander G., et al.
Publicado: (2020)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Linking the Metabolic State and Mitochondrial DNA in Chronic Disease, Health, and Aging
por: Picard, Martin, et al.
Publicado: (2013)

Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
por: Titchenell, Paul M., et al.
Publicado: (2013)

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
por: Neel, Brian A., et al.
Publicado: (2011)

Navigating the Depths and Avoiding the Shallows of Pancreatic Islet Cell Transcriptomes
por: Mawla, Alex M., et al.
Publicado: (2019)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions
por: Nathan, David M., et al.
Publicado: (2013)

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
por: Bozadjieva, Nadejda, et al.
Publicado: (2018)

Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions
por: Halter, Jeffrey B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gqn39o3l4qt9l5mmo5kuo8ucbs